医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2013年
16期
100-100
,共1页
生长抑素%治疗%肠梗阻
生長抑素%治療%腸梗阻
생장억소%치료%장경조
Somatostatin%Remedy%Intestinal obstruction
目的观察生长抑素治疗炎性肠梗阻的临床效果。方法将我院2011年1月～2012年12月期间收治的92例炎性肠梗阻患者随机分为两组，即观察组46例，对照组46例。对照组患者行常规治疗，观察组患者在常规治疗的基础上行生长抑素治疗。分别观察两组患者的临床治疗效果，及胃肠减压量、腹痛缓解时间、肛门排气排便时间、住院时间。结果观察组46例患者临床治疗的治愈率为97.83%，对照组为86.96%。两组比较，差异具有统计学意义（P＜0.05）。观察组46例患者的平均每日胃肠减压量明显少于对照组，腹痛缓解时间、肛门排气排便时间及住院时间均明显短于对照组，两组比较，差异具有显著性（P＜0.01）。结论生长抑素治疗炎性肠梗阻的临床效果显著，能明显减少胃肠减压量，缩短腹痛缓解时间、肛门排气排便时间及住院时间。
目的觀察生長抑素治療炎性腸梗阻的臨床效果。方法將我院2011年1月～2012年12月期間收治的92例炎性腸梗阻患者隨機分為兩組，即觀察組46例，對照組46例。對照組患者行常規治療，觀察組患者在常規治療的基礎上行生長抑素治療。分彆觀察兩組患者的臨床治療效果，及胃腸減壓量、腹痛緩解時間、肛門排氣排便時間、住院時間。結果觀察組46例患者臨床治療的治愈率為97.83%，對照組為86.96%。兩組比較，差異具有統計學意義（P＜0.05）。觀察組46例患者的平均每日胃腸減壓量明顯少于對照組，腹痛緩解時間、肛門排氣排便時間及住院時間均明顯短于對照組，兩組比較，差異具有顯著性（P＜0.01）。結論生長抑素治療炎性腸梗阻的臨床效果顯著，能明顯減少胃腸減壓量，縮短腹痛緩解時間、肛門排氣排便時間及住院時間。
목적관찰생장억소치료염성장경조적림상효과。방법장아원2011년1월～2012년12월기간수치적92례염성장경조환자수궤분위량조，즉관찰조46례，대조조46례。대조조환자행상규치료，관찰조환자재상규치료적기출상행생장억소치료。분별관찰량조환자적림상치료효과，급위장감압량、복통완해시간、항문배기배편시간、주원시간。결과관찰조46례환자림상치료적치유솔위97.83%，대조조위86.96%。량조비교，차이구유통계학의의（P＜0.05）。관찰조46례환자적평균매일위장감압량명현소우대조조，복통완해시간、항문배기배편시간급주원시간균명현단우대조조，량조비교，차이구유현저성（P＜0.01）。결론생장억소치료염성장경조적림상효과현저，능명현감소위장감압량，축단복통완해시간、항문배기배편시간급주원시간。
Objective:To observe the clinical ef icacy of somatostatin in the treatment of inflammatory intestinal obstruction. Methods: randomly divided 92 cases of inflammatory intestinal obstruction patients in our hospital in 2011 January~2012 December admit ed into 2 groups,the observation group 46 cases,control group 46 cases. Routine treatment group,on the basis of observation group patients in the conventional treatment of somatostatin treatment. Clinical therapeutic ef ect of 2 groups of patients were observed, and the amount of gastrointestinal decompression,abdominal pain relief time, defecation time,anus exhaust time in hospital. Results: the observation group 46 cases of clinical treatment of patients with the cure rate was 97.83%, control group 86.96%. Comparing the 2 groups,the dif erence was statistical y significant (P<0.05).Observation on the average daily amount of gastrointestinal decompression group of 46 patients was less than that in the control group,abdominal pain relief time,defecation time exhaust the anus and the hospitalization were significantly shorter than the control group,the 2 groups, the dif erence was significant (P<0.01). Conclusion:the clinical ef ect of somatostatin in the treatment of inflammatory bowel obstruction is significant,can significantly reduce the amount of gastrointestinal decompression,abdominal pain relief time,shorten defecation time exhaust anal and hospitalization time.
